Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

davids - v.g.d. pty. limited - phenothrin-d | tetramethrin - household insecticide - no uses entered for this product - no usages entered

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - paroxetine hydrochloride hemihydrate -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - glufosinate-ammonium - soluble concentrate - glufosinate-ammonium organophosphorus-phosphinic ac active 200.0 g/l - herbicide - avocado | banana | blackberry | boysenberry | cane berry fruit | citrus fruit orchard | commercial/industrial land | feijoa | gu - amaranth or amaranthus | apple-of-peru | argentine peppercress | awnless barnyard grass | barley grass | barnyard grass or water grass | billygoat weed or blue top | bittercress or swinecress | black bindweed | bladder ketmia | blady grass | bordered panic | brome grass | caltrop or yellow vine | cape tulip | capeweed | centro | clover | clover glycine | cobbler's pegs | common pigweed | common sida | common storksbill | couch grass | cowpea | crowsfoot grass | deadnettle | dwarf crumbweed | fat hen | fumitory | giant sensitive plant | green crumbweed | greenleaf desmodium | johnson grass | lesser canary grass | liverseed or urochloa grass | medic | mintweed | new zealand spinach | panic | paspalum spp. | paterson's curse | peanut mite | perennial bindweed or convolvulus | pigeon grass | pinkburr | potato or yellow weed | prairie grass | prickly lettuce | primocane control | red natal grass | saffron thistle | sago weed | scarlet or red pimpernel | shamrock | sheep, shore or winged slender thistle | silver gr

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - paroxetine hydrochloride, quantity: 22.2 mg - tablet, film coated - excipient ingredients: mannitol; titanium dioxide; magnesium stearate; copovidone; colloidal anhydrous silica; microcrystalline cellulose; hypromellose; sodium starch glycollate; purified talc - paroxetine gh is indicated for the treatment of : - major depression and for the prevention of relapse of depressive symptoms - obsessive compulsive disorder (ocd) and prevention of relapse of ocd - panic disorder and for the prevention of relapse of panic disorder - social anxiety disorder/social phobia - general anxiety disorder - post-traumatic stress disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - venlafaxine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.2 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate; lactose; hyprolose; hypromellose; macrogol 8000; titanium dioxide - treatment of major depression and prevention of relapse of depressive symptoms. treatment of obsessive compulsive disorder (ocd) and prevention of relapse of ocd. treatment of panic disorder and prevention of relapse of panic disorder. treatment of social anxiety disorder / social phobia. treatment of generalised anxiety disorder. treatment of post-traumatic stress disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.22 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; mannitol; basic butylated methacrylate copolymer; titanium dioxide; purified talc; polyvinyl alcohol; sodium lauryl sulfate; glyceryl monostearate - treatment of major depression and for the prevention of relapse of depressive symptoms; treatment of obsessive compulsive disorder and for the prevention of relapse of ocd; treatment of panic disorder and for the prevention of relapse of panic disorder; treatment of social anxiety disorder/ social phobia; treatment of generalised anxiety disorder; and treatment of post-traumatic stress disorder

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - paroxetine hydrochloride hemihydrate, quantity: 22.2 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; sodium starch glycollate type a; calcium hydrogen phosphate dihydrate; calcium hydrogen phosphate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - for the treatment of:,? major depression and for the prevention of relapse of depressive symptoms;,? obsessive compulsive disorder and for the prevention of relapse of ocd;,? panic disorder and for the prevention of relapse of panic disorder;,? social anxiety disorder/social phobia; and,? generalised anxiety disorder;,? posttraumatic stress disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - paroxetine hydrochloride hemihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - paroxetine hydrochloride -